Article

How the Management of Biochemical Recurrence in Prostate Cancer Will be Modified by the Concept of Anticipation and Incrementation of Therapy

2024-01-04

Abstract excerpt

Biochemical recurrence (BCR) after primary treatments for prostate cancer (PC) is an extremely heterogeneous phase and at least a stratification in low and high-risk cases for early progression in metastatic disease is necessary. At now PSA-DT represents the best parameter to define low and high risk BCR PC, but a real precision medicine is strongly suggested to define a tailored management of patients with BCR. B...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1c9dbafe-1c3e-5712-b568-82a03aa1cb36
DOI: 10.20944/preprints202401.0407.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

How the Management of Biochemical Recurrence in Prostate Cancer Will be Modified by the Concept of Anticipation and Incrementation of TherapyDOI 10.20944/preprints202401.0407.v1Read

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read

Usefulness of Tissue Biomarkers versus Prostate-Spcific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical ProstatectomySemantic proximity Read

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.Semantic proximity Read

Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerSemantic proximity Read

Is It Time to Anticipate the Use of Parp Inhibitors in Prostate Cancer Patients?Semantic proximity Read

[Metastatic castration-resistant prostate cancer-emerging trends in therapy].Semantic proximity Read

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.Semantic proximity Read

Patients with Positive Lymph Nodes after Radical Prostatectomy with Pelvic Lymphadenectomy – Do We Know the Proper Way of Management?Semantic proximity Read

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy: 5-year follow-up of a nationwide real-world cohortSemantic proximity Read

Current State of Adjuvant Hormone Therapy in Prostate Cancer and in the Management of Pelvic Nodal Recurrence: A Narrative ReviewSemantic proximity Read

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrenceSemantic proximity Read